2-(4-(3-Chlorophenyl)piperazin-1-yl)ethan-1-amine → 1-t-Butyl-3-{2-[4-(3-chlorophenyl)piperazin-1-yl]ethyl}aminomethyl-5-propyl pyrazole
Reaktionsgleichung
[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[CH2:13][CH2:12][N:11]([CH2:14][CH2:15][NH2:16])[CH2:10][CH2:9]2)[CH:5]=[CH:6][CH:7]=1.[CH2:17]([C:20]1[N:24]([C:25]([CH3:28])([CH3:27])[CH3:26])[N:23]=[C:22]([CH:29]=O)[CH:21]=1)[CH2:18][CH3:19]>>[C:25]([N:24]1[C:20]([CH2:17][CH2:18][CH3:19])=[CH:21][C:22]([CH2:29][NH:16][CH2:15][CH2:14][N:11]2[CH2:10][CH2:9][N:8]([C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[CH:3]=3)[CH2:13][CH2:12]2)=[N:23]1)([CH3:28])([CH3:27])[CH3:26]Komponenten
3
Versuchsvorschrift
Compound 75 was prepared using the same method as that of Example 1 except that 4-(3-chlorophenyl)piperazin-1-ylethylamine and 5-propyl-1-t-butylpyrazole-3-carbaldehyde were used.
Quellen und Nachweise
- ORD-Eintrag
- ord-0ddb83b803974e9489b3944b6fbc8547
- Quelldatensatz
- uspto-grants-2009_06